Nature Reviews Drug Discovery
Brief Name:
NAT REV DRUG DISCOV
Impact factor:
122.7 (2023)
ISSN:
1474-1776
Home Page:
Open Access:
No
Publisher:
Nature Publishing Group
Publication Frequency:
Monthly
Publication Start Year:
2002
Annual Articles:
37
Self-citation Rate:
0.4%
Chinese Academy of Sciences SCI Journal Classification:
| Major category | Ｍinor category | TOP journal | Ｒeview journal |
|---|---|---|---|
Q1 MEDICAL |
BIOENGINEERING AND APPLIED MICROORGANISMS | Yes | Yes |
Subject Classification:
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
CiteScore:
| CiteScore | SJR | SNIP | CiteScore ranking | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 137.4 | 22.399 | 19.36 |
|
H-Index:
289
SCI Index Status:
Science Citation Index Expanded
PubMed Central:
Submission Site:
Aims and Scope:
Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering a broad scope, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in areas such as new drug approvals, patent law and emerging industry trends and strategies.
Submission Guidelines:
Types of Articles Accepted:
Reviews, Perspective
Reference Citations Format:
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.